HeartBeam, Inc. BEAT

Company Overview

HeartBeam, Inc. is a medical technology company focused on cardiac monitoring and cardiac diagnostic solutions. The company develops electrocardiogram (ECG) technologies intended to improve the detection and monitoring of heart disease outside of traditional clinical settings. HeartBeam operates within the digital health, remote patient monitoring, and cardiovascular diagnostics industries, with an emphasis on portable and ambulatory cardiac assessment tools. Its primary revenue and strategic focus have centered on the development and commercialization of proprietary ECG hardware, software, and cloud-based analytics designed to capture heart signals from multiple directions and provide physicians with data comparable to traditional in-office cardiac testing.

The company’s core technology platform is designed around a credit card–sized ECG device capable of collecting three-dimensional cardiac electrical signals. HeartBeam positions its technology as an alternative to conventional single-lead wearable monitors by seeking to provide higher-fidelity cardiac data for arrhythmia and ischemia evaluation. The company evolved from an early-stage cardiac technology developer into a publicly traded digital health company through a merger transaction involving a special purpose acquisition company in 2021. Since then, HeartBeam has focused on regulatory advancement, software integration, physician connectivity, and commercialization planning within the broader remote cardiovascular care market.